Navigation Links
Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich's Genous™ Stent in Diabetic Patients
Date:3/23/2011

, an average of 1.4 lesions per patient was treated, with an average of 1.1 Genous Stents per lesion. Off all lesions, 10 percent were bifurcation lesions, 97 percent were de novo lesions, and 48 percent were type B2/C lesions.

Michael Kutryk, M.D., Ph.D., clinician scientist and an interventional cardiologist at St. Michael's Hospital, as well as an assistant professor at the University of Toronto, added, "Patients with cardiovascular risk factors, including diabetes, have a reduced number of circulating endothelial progenitor cells (EPCs) that is due to either a direct influence on the mobilization and half-life of the EPCs or to a depletion of these cells caused by continuous endothelial damage or dysfunction. Capturing circulating EPCs with the unique Genous technology promotes and restores the natural healing process that is impaired in diabetics."

About Genous

Genous is OrbusNeich's patented EPC capture technology that promotes the accelerated natural healing of the vessel wall after the implantation of blood-contact devices such as stents. The technology consists of an antibody surface coating that attracts EPCs circulating in the blood to the device to form an endothelial layer that provides protection against thrombosis and modulates restenosis.

The Genous Stent, which  has been commercially available in more than 60 countries since 2005, has been proven as a safe, effective alternative to drug-eluting stents and is supported by data from more than 5,000 patients in company-sponsored clinical studies. There is a growing body of evidence from multiple clinical studies that the Genous Stent is effective for patients who are non-responsive to or cannot tolerate long-term dual antiplatelet therapy.

About OrbusNeich

OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world's f
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Findings From Excellagen Matrix Clinical Study Published in Peer-Reviewed Journal Wound Repair and Regeneration
2. German High Court Rules in Favor of AmniSure® as New European Guidelines Published
3. Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
4. Analysis of Calipers Phase I EPA ToxCast™ Data Published in Leading Scientific Journal
5. Published Data From e-HEALING Registry Demonstrate Good Clinical Outcomes With Low Incidence of Repeat Revascularization and Stent Thrombosis for OrbusNeichs Genous™ Stent
6. Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
7. CHAMPION Study Published in The Lancet
8. Data on DermTechs Non-invasive Test for Melanoma Are Published in the British Journal of Dermatology
9. New Published Study Finds Noninvasive Masimo PVI Accurately Predicts Fluid Responsiveness in Intensive Care Patients
10. Newly Published Data Demonstrates Caldolor® Significantly Reduces Pain and Morphine Use in Post-Operative Patients
11. First Five-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  When ... along the side of his neck, he ... took a couple weeks off from weight ... go away.                               A ... 26, was referred to Michel Kliot, ...
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... and size the world market for Arthroscopy ... identifies trends impacting the market for these ...
(Date:5/21/2015)... , May 21, 2015  (MUSE Booth # ... Health Record (EHR) is invaluable in any hospital ... are now a requirement and mainstream in healthcare, ... into the EHR is gaining traction in MEDITECH ... Holmes, RN, Site Project Manager & Clinical Analyst ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3
... Trial Supported by the Foundation Fighting Blindness ... New England Journal of Medicine, OWINGS MILLS, Md., April ... to patients who were nearly blind from,a condition known as ... Initial results from the clinical trial, which was,funded in part ...
... April 26 Schering-Plough Corporation,(NYSE: SGP ) ... analysis of,an ongoing Phase II study of boceprevir, ... treatment-naive patients with chronic,hepatitis C virus (HCV) genotype ... the European Association for the Study of the ...
Cached Medicine Technology:Gene Therapy Provides Vision to People who Were Nearly Blind 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 2Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 3Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 4Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 5Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 6Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 7Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 8Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL 9
(Date:5/22/2015)... OR (PRWEB) May 22, 2015 Pioneer ... remains at the forefront of designing with reclaimed wood, ... Design in Los Angeles, California. Their newest offerings, Vat ... bring much-anticipated surface and color to America's largest design ... our exhibit at each show, anxious to see and ...
(Date:5/22/2015)... Halifax, NS (PRWEB) May 22, 2015 ... into a sale agreement with US-based health brand Nature’s ... Ascenta Skin brand. Retention of Ascenta Skin is an ... St-Onge is excited about this opportunity to further develop ... industry. , Ascenta Skin is a breakthrough, anti-aging ...
(Date:5/22/2015)... 2015 Family, friends, students, colleagues, mentors ... oncologist, Dr. LaSalle D. Leffall, on Monday, May 18, ... after Grand Rounds in the hospital’s Tower Auditorium. Leffall’s ... the auditorium, trying to keep the secret. “I’d like ... sees me, he’ll know something is up,” she said. ...
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship ... Drobeck is in his second year of racing in the ... Missoula Fire Department in Missoula, MT. He entered the triathlon ... his career, he has had 15 1st Place finishes. In ... finishes in all seven of his 2014 races, including two ...
(Date:5/22/2015)... Gateway Building Concepts is experienced with all forms ... specialize in include decks, additions, kitchen remodeling, interior renovations, ... more. , The redesigned logo is a fresh ... It includes two geometrical lines that represent the engineering ... be used with many things associated with the company. ...
Breaking Medicine News(10 mins):Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2
... Oregon Health & Science University Cancer Institute researcher has ... survival for men with advanced prostate cancer. The C-reactive ... of protein produced by the liver that is elevated ... a simple blood test that is already available could ...
... Inspired by the popular television drama CSI, investigators in ... at crime scenes to highlight infection risks in their ... used by crime scene investigators, to detect traces of ... amounts of blood to produce bright blue luminescence, which ...
... can hold a credit card, use a keyboard with the ... kg the worlds first commercially available pros-thetic hand that ... of grip configurations. For the first time worldwide a patient ... the i-LIMB hand in comparison with another innovative prosthesis, the ...
... Hail from San Francisco Bay Area, Northern ... ... the Harker School in San Jose, Calif., and Connie Yu, a,seventh-grader at ... second prize winners, respectively, of the United Nations,Environment Programme,s (UNEP) 17th annual ...
... Angiogenesis, the growth of new blood vessels, is ... situations such as healing of wounds and traumas, ... and in cancer growth. The current belief about ... (ECs) responsible for vascular growth in adults is ...
... transforming healthcare by making medical care more accessible and convenient to, ... following problems that plague patients and practitioners in today,s ... inefficient U.S. healthcare system:, * Doctors are hard to see. As ... one-in-four have problems ...
Cached Medicine News:Health News:OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival 2Health News:Each finger can be moved separately 2Health News:Each finger can be moved separately 3Health News:United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Children's Painting Competition 2Health News:United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Children's Painting Competition 3Health News:United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Children's Painting Competition 4Health News:A stem cell type supposed to be crucial for angiogenesis and cancer growth does not exist? 2Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 2Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 3Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 4Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 5Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 6
... developed a minimally invasive cryocatheter to ... delivers a very high level of ... site precision, minimal tissue disruption, and ... ,Freezor Xtra allows physicians to surgically ...
The Medtronic StableMapr catheter is intended for use in diagnostic electrophysiologic procedures. These catheters are designed for recording intracardiac electrograms and temporary pacing associated...
... The NAVI-STAR catheter is specifically designed for ... Our precision EP deflectable NAVI-STAR catheter houses ... tip to indicate, in real time, exact ... simultaneously collecting local electrogram information. The NAVI-STAR ...
... Biosense Webster offers a complete ... mapping in the atrium. The ISMUS ... for simple placement in the atrial ... on the catheter's distal tip permit ...
Medicine Products: